- Home
- LANV vs RGC Comparison
LANV vs RGC Comparison
Compare LANV & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$5.88
Company Overview
Basic Information| Metric | LANV | RGC |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | China | Hong Kong |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.0M | 3.1B |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | LANV | RGC |
|---|---|---|
| Price | $1.05 | $5.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 39.6K | ★ 163.2K |
| Earning Date | 04-30-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.33 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.95 | $4.51 |
| 52 Week High | $2.31 | $69.00 |
Technical Indicators
Market Signals| Indicator | LANV | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 46.57 | 49.33 |
| Support Level | $1.03 | $4.71 |
| Resistance Level | $1.14 | $6.40 |
| Average True Range (ATR) | 0.07 | 0.57 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 55.53 | 29.96 |
Price Performance
Historical Comparison LANV
RGC
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the St. John segment.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.